Jeffrey Mendelson, MD
Orthopaedic Surgery · Warren, MINPI 1396735106
Payments from drug & device makers
Across 50 payments — averaging $134.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$6K
- Stryker$304
- Bioness Inc$137
- Dynasplint Systems Inc.$69
- Medtronic$52
- Lundbeck LLC$51
- plus $252 from 13 others
What the payments were for
- Travel & lodging$4,50467%
- Food & beverage$2,21633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 26 | $5,855 |
| Stryker | 2 | $304 |
| Bioness Inc | 1 | $137 |
| Dynasplint Systems Inc. | 1 | $69 |
| Medtronic | 3 | $52 |
| Lundbeck LLC | 2 | $51 |
| Amgen | 3 | $36 |
| Treace Medical Concepts, Inc. | 1 | $28 |
| Si-bone, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Pinnacle, Inc | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $15 |
| AbbVie | 1 | $13 |
| Linvatec Corporation | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,721 in reported general payments places this provider in the 65th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Potassium | 38 | $22,386 |
| Diclofenac Sodium | 31 | $9,740 |
| Chlorzoxazone | 21 | $9,093 |
| Celecoxib | 56 | $1,893 |
| Lidocaine | 29 | $1,196 |
| Naproxen Sodium | 19 | $789 |
| Methylprednisolone | 36 | $222 |
| Ibuprofen | 11 | $120 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $118 |
| Tramadol Hcl | 11 | $52 |
| Amoxicillin | 27 | $45 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Warren
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$5.7M
- Jad KhalilSouthfield$3.7M
- Mark PintoChelsea$3.2M
- Kyle AndersonBingham Farms$3.1M
- Stephen BartolDetroit$2.6M
- Jeffrey FischgrundSouthfield$1.8M
- David MarkelSouthfield$1.7M
- Richard EastonRochester Hills$1.6M
- Shariff BishaiTroy$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.